Decreased vitamin D levels in obsessive-compulsive disorder patients.

Vitamin D biomarkers central nervous system obsessive-compulsive disorder pharmacological treatments

Journal

CNS spectrums
ISSN: 1092-8529
Titre abrégé: CNS Spectr
Pays: United States
ID NLM: 9702877

Informations de publication

Date de publication:
Oct 2023
Historique:
pubmed: 24 9 2021
medline: 24 9 2021
entrez: 23 9 2021
Statut: ppublish

Résumé

The present paper compared vitamin D levels in adult patients with obsessive-compulsive disorder (OCD) and explored possible correlations with patients' characteristics. Fifty outpatients with OCD, according to DSM-5 criteria, were included and assessed with the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and the Hamilton Rating Scale for Depression (HRDS). All the patients except one showed lower vitamin D levels than normative values (>30 nm/L). Vitamin D values of the whole sample were negatively correlated with Y-BOCS total, compulsion subscale, and some items' scores, specifically "interference from obsessions," "distress associated with obsessions," and "time spent on compulsions". The same relationships were detected in men, while women showed negative correlations between vitamin D levels and Y-BOCS compulsion subscale and "resistance to compulsions," "degree of control of compulsions," "insight" item scores. Our findings would indicate that vitamin D might be involved in the pathophysiology of OCD, and that it is possibly related to the severity of the disorder and to typical symptoms, with some sex-related peculiarities. Further studies are necessary to support or not our findings and to ascertain the effectiveness of vitamin D supplementation in patients with OCD.

Identifiants

pubmed: 34551844
doi: 10.1017/S1092852921000821
pii: S1092852921000821
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

606-613

Auteurs

Donatella Marazziti (D)

Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy.
Saint Camillus International University of Health and Medical Sciences, Rome, Italy.

Filippo M Barberi (FM)

Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy.

Leonardo Fontenelle (L)

Institute of Psychiatry of the Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Department of Psychiatry, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.

Beatrice Buccianelli (B)

Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy.

Manuel G Carbone (MG)

Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy.

Elisabetta Parra (E)

Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy.

Stefania Palermo (S)

Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy.

Lucia Massa (L)

Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy.

Claudia Tagliarini (C)

Department of Mental Health, National Health Service, ASST Cremona, Cremona, Italy.

Alessandra Della Vecchia (A)

Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy.

Federico Mucci (F)

Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy.

Alessandro Arone (A)

Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy.

Liliana Dell'Osso (L)

Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy.

Classifications MeSH